• chromosome
  • Because chromosome 5 is responsible for many forms of growth and development (cell divisions) changes may cause cancers. (wikipedia.org)
  • Other changes in the number or structure of chromosome 5 can have a variety of effects, including delayed growth and development, distinctive facial features, birth defects, and other medical problems. (wikipedia.org)
  • Expression
  • METHODS Using human pancreatic tissues obtained from patients with chronic pancreatitis and murine pancreatic tissues obtained from transgenic mice overexpressing transforming growth factor α (TGF-α), the expression and cellular distribution of TFF1 was analysed using northern blot analysis, polymerase chain reaction (PCR), and immunohistochemistry. (bmj.com)
  • 5-8 These observations suggest that changes in the pattern of growth factor expression may be involved in the pathophysiological processes that occur in chronic pancreatitis. (bmj.com)
  • Therefore, we investigated the impact of YB-1 expression on the clinical outcome in breast cancer patients ( n = 83) and compared it with expression of the tumor-biologic factors HER2, 7 urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1), 8 which are already in use for clinical decision making. (wiley.com)
  • exon
  • Alternative splicing occurs and additional variants have been described, including those utilizing alternate exon 8 rather than 9, but their full-length nature has not been determined. (wikipedia.org)
  • Molecular
  • 8. A composition according to claim 1 , the first polymer component having a molecular weight from about 30 kilodaltons to about 500 kilodaltons. (google.co.uk)
  • Thyroid-derived chondrocyte stimulating factor (TDCSF) is a high molecular weight complex (greater than 500 kd) of proteinaceous subunits which can be at least partially dissociated into active portions by 8M urea. (patentgenius.com)
  • wherein
  • 6. A composition according to claim 1 wherein the first polymer component includes copolymers prepared from alkylenes that comprise from 3 to 8 carbon atoms. (google.co.uk)
  • 8. The method of claim 1 , wherein the osteogenic precursor cells are transfected ex vivo. (google.com)
  • 8. The array of claim 7, wherein said array further comprises a plurality of saccharide binding agents as calibration standards in predetermined locations on said planar substrate. (patentsencyclopedia.com)
  • 9. The array of claim 8, wherein said planar substrate is divided to a plurality of pads and wherein each pad comprises a separate plurality of calibration standards. (patentsencyclopedia.com)
  • 8 . The biointerface membrane according to claim 1 , wherein the bioactive agent comprises an anti-barrier cell agent. (google.es)
  • 9 . The biointerface membrane according to claim 8 , wherein the anti-barrier cell agent is selected from the group consisting of an anti-inflammatory agent, an anti-infective agent, an anesthetic, and mixtures thereof. (google.es)
  • 10 . The biointerface membrane according to claim 8 , wherein the anti-barrier cell agent employs a mechanism configured to speed up a host infiltration of the interconnected cavities by inhibiting at least one of foreign body giant cells and occlusive cell layers. (google.es)
  • 11 . The biointerface membrane according to claim 8 , wherein the anti-barrier cell agent comprises Super Oxide Dismutase Mimetic. (google.es)
  • 8 . The medical device of claim 1 , wherein the biocompatible matrix comprises a naturally-occurring material selected from the group consisting of collagen, elastin, laminin, fibronectin, vitronectin, heparin, fibrin, cellulose and amorphous carbon. (google.ca)
  • incorporation
  • Skin healing can be altered by changing the configuration (pore size, porosity, fiber diameter), the surface (composition, charge, surface energy), the biochemical activity (incorporation of growth factors or other biochemical factors), or the degradation or drug delivery rate of the wound dressing. (tamucc.edu)
  • vascular
  • 1,3 ⇓ OxLDL induces a number of cytokines and growth factors in vascular cells, exerts mitogenic effects at low concentrations and cytotoxic effects at high concentrations, and are also implicated in the progression of the plaque to vulnerable, highly thrombogenic atheroma. (ahajournals.org)